IFCT-1602 CHIVA2 phase II trial: Nivolumab in previously treated HIV-patients with advanced nonsmall cell lung cancer (NSCLC)

  • Etude concernée: IFCT-1602
  • Auteurs / Authors: A. Lavole, J. Mazieres, S. Schneider, S. Brosseau, L.M. Kiakouama, L. Greillier, A. Guihot, B. Abbar, M. Baron, A. Makinson, A. Langlais, F. Morin, J-P. Spano, J. Cadranel
  • Journal / Conference: ESMO
  • Année / Year: 2020
  • PMID: Poster
  • Lien vers la publication: https://www.annalsofoncology.org/article/S0923-7534(20)41699-0/abstract